Breast cancer is highly heterogeneous and can be identified by the expression states of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2) into four intrinsic subtypes. This evidence concerns the gene ERBB2 and breast cancer.